210
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Comparison of polyvinyl alcohol and tris-acryl gelatin microsphere materials in embolization for symptomatic leiomyomas: a systematic review

, , , &
Pages 289-300 | Received 31 Mar 2016, Accepted 03 Jun 2016, Published online: 19 Jul 2016

References

  • Stein K, Ascher-Walsh C. A comprehensive approach to the treatment of uterine leiomyomata. Mt Sinai J Med 2009;76:546–56.
  • Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, Sabbatini P, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol 2009;112:563–7.
  • Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100–7.
  • Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli AM. Uterine artery embolization versus myomectomy: impact on quality of life–results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovasc Intervent Radiol 2012;35:530–6.
  • Horhoianu IA, Horhoianu VV, Joita D, Carstoiu M, Dorobat B. Uterine artery embolization for leioyomas, ultrasonography and angiography aspects. J Med Life 2012;5:491–5.
  • Ananthakrishnan G, Murray L, Ritchie M, Murray G, Bryden F, Lassman S, et al. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings. Cardiovasc Intervent Radiol 2013;36:676–81.
  • Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2012;5:CD005073.
  • Martin J, Bhanot K, Athreya S. Complications and reinterventions in uterine artery embolization for symptomatic uterine fibroids: a literature review and meta analysis. Cardiovasc Intervent Radiol 2013;36:395–402.
  • Song YG, Jang H, Park KD, Kim MD, Kim CW. Non spherical polyvinyl alcohol versus gelatin sponge particles for uterine artery embolization for symptomatic fibroids. Minim Invasive Ther Allied Technol 2013;22:364–71.
  • Spies JB, Cornell C, Worthington-Kirsch R, Lipman JC, Benenati JF. Long-term outcome from uterine fibroid embolization with tris-acryl gelatin microspheres: results of a multicenter study. J Vasc Interv Radiol 2007;18:203–7.
  • Bilhim T, Pisco JM, Duarte M, Oliveira A. Uterine fibroid embolization with PVA: does the size of PVA particles matter? J Vasc Interv Radiol 2010;1:S21–S2.
  • Abramowitz SD, Israel GM, McCarthy SM, Pollak JS, White RI Jr., Tal MG. Comparison of four embolic materials at uterine artery embolization by using postprocedural MR imaging enhancement. Radiology 2009;250:482–7.
  • Siskin GP, Englander M, Stainken BF, Ahn J, Dowling K, Dolen EG. Embolic agents used for uterine fibroid embolization. AJR Am J Roentgenol 2000;175:767–73.
  • Lampmann LE, Smeets AJ, Lohle PN. Uterine fibroids: targeted embolization, an update on technique. Abdom Imaging 2004;29:128–31.
  • Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol 2004;15:793–800.
  • Spies JB, Allison S, Flick P, Cramp M, Bruno J, Jha RC, et al. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. J Vasc Interv Radiol 2005;16:1431–7.
  • Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr A. Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol 2008;19:58–65.
  • Worthington-Kirsch RL, Siskin GP, Hegener P, Chesnick R. Comparison of the efficacy of the embolic agents acrylamido polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: a prospective randomized controlled trial. Cardiovasc Intervent Radiol 2011;34:493–501.
  • Yu SC, Lok I, Ho SS, Tong MM, Hui JW. Comparison of clinical outcomes of tris-acryl microspheres versus polyvinyl alcohol microspheres for uterine artery embolization for leiomyomas: results of a randomized trial. J Vasc Interv Radiol 2011;22:1229–35.
  • Shlansky-Goldberg RD, Rosen MA, Mondschein JI, Stavropoulos SW, Trerotola SO, Diaz-Cartelle J. Comparison of polyvinyl alcohol microspheres and trisacryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study. J Vasc Interv Radiol 2014;25:823–32.
  • Chua GC, Wilsher M, Young MP, Manyonda I, Morgan R, Belli AM. Comparison of particle penetration with non-spherical polyvinyl alcohol versus trisacryl gelatin microspheres in women undergoing premyomectomy uterine artery embolization. Clin Radiol 2005;60:116–22.
  • Galvez JA, McCarthy S, Weinreb J, Zelterman D, White RI, Pollak J, et al. Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using tris-acryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles. J Comput Assist Tomogr 2008;32:356–61.
  • Shlansky-Goldberg R, Rosen M, Mondschein J, Stavropoulous SW, Trerotola SO. Randomized comparison of polyvinyl alcohol and tris-acryl gelatin microspheres for uterine fibroid embolization. J Vasc Interv Radiol 2010;21:1927.
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration 2011. England: John Wiley & Sons Ltd. Available from www.cochrane-handbook.org
  • Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290–300.
  • Orsini L, Salardi S, Pilu G, Bovicelli L, Cacciari E. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology 1984;153:113–6.
  • Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB, Landow WJ, et al. Reporting Standards for Uterine Artery Embolization (UAE) Subcommittee, UAE Task Force Standards Subcommittee, Society of Interventional Radiology Technology Assessment Committee. Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 2003;14:S467–S76.
  • Spies JB. What evidence should we demand before accepting a new embolic material for uterine artery embolization? J Vasc Interv Radiol 2009;20:567–70.
  • Rasuli P, Hammond I, Al-Mutairi B, French GJ, Aquino J, Hadziomerovic A, et al. Spherical versus conventional polyvinyl alcohol particles for uterine artery embolization. J Vasc Interv Radiol 2008;19:42–6.
  • Laurent A, Beaujeux R, Wassef M, Rüfenacht D, Boschetti E, Merland JJ. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. AJNR Am J Neuroradiol 1996;17:533–40.
  • Derdeyn CP, Graves VB, Salamat MS, Rappe A. Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics. AJNR Am J Neuroradiol 1997;18:647–53.
  • Choe DH, Han MH, Kang GH, Yeon KM, Han MC. An experimental study of embolic effect according to infusion rate and concentration of suspension in transarterial particulate embolization. Invest Radiol 1997;32:260–7.
  • Laurent A, Wassef M, Namur J, Martal J, Labarre D, Pelage JP. Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study. Fertil Steril 2009;91:884–92.
  • Choi HJ, Jeon GS, Kim MD, Lee JT, Yoon JH. Is uterine artery embolization for patients with large myomas safe and effective? A retrospective comparative study in 323 patients. J Vasc Interv Radiol 2013;24:772–8.
  • Sampson JA. The blood supply of uterine myomata. Surg Gynecol Obstet 1912;14:215–34.
  • Di Stas C, Cina A, Tropeano G, Amoroso S, Scambia G. Prospective study to investigate risk factors for clinical failure of uterine fibroid embolization. J Vasc Interv Radiol 2013;24:e12–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.